Virtu Financial LLC Aptinyx Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$0.12 - $0.69 $33,651 - $193,496	280,430 New	280,430 $35,000
Q3 2022 Nov 07, 2022	BUY	$0.35 - $0.72 $8,332 - $17,140	23,806 New	23,806 $9,000
Q2 2022 Aug 09, 2022	SELL	$0.38 - $2.58 $4,441 - $30,155	-11,688 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$2.27 - $3.62 $26,531 - $42,310	11,688 New	11,688 $27,000
Q3 2021 Nov 12, 2021	SELL	$2.21 - $2.89 $177,246 - $231,783	-80,202 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$2.39 - $3.5 $191,682 - $280,707	80,202 New	80,202 $227,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.